Store-operated Ca 2+ entry (SOCE) mediated by stromal interacting molecule-1 (STIM1) and
INTRODUCTION
Store-operated Ca 2+ entry (SOCE) is the main mechanism of Ca 2+ influx into the non-excitable cells and regulates Ca 2+ homeostasis in excitable cells including neurons, skeletal muscle cells and cardiomyocytes [1] [2] [3] . A major function of SOCE is to refill the depleted sarcoplasmic/endoplasmic reticulum (SR/ER) Ca 2+ stores via elevations in cytosolic Ca 2+ sourced from the extracellular space. Increases in cytosolic Ca 2+ by SOCE also regulate various cellular functions including exocytosis, muscle contraction, cell mobility, gene transcription, cell proliferation and apoptosis [3] . Stromal interaction molecules (STIM1 and 2) and Orai family members (Orai1-3) are proteins involved in the activation and formation of Ca 2+ release activated Ca 2+ (CRAC) channels, which mediate a highly Ca 2+ -selective conductance (I CRAC ) and represent a major SOCE pathway [3] . STIM1 is a single pass transmembrane protein that is primarily localized to the SR/ER membrane. The EF-hand and the sterile alpha motif (SAM) domains function to sense decreases in SR/ER luminal Ca 2+ levels through a mechanism which couples a destabilization of the EF-hand:SAM domain interface with dimerization and oligomerization [4] [5] [6] . Moreover, the oligomerization of this EF-SAM region induces a conformational rearrangement on the cytosolic portion of STIM1 that culminates in translocation of STIM1 molecules to SR/ER-plasma membrane junctions where Orai1 subunits are recruited, assembled into channels and gated to permit Ca 2+ entry into the cytosol [7] [8] [9] . Apart from SR/ER Ca 2+ levels, STIM1 is sensitive to transient temperature increases such that cooling allows heatactivated STIM1 to couple with Orai-formed channels [10] . Additionally, post-translational modifications including phosphorylation, N-glycosylation and O-GlcNAcylation, regulate STIM1-Orai1 coupling and SOCE activation [10] [11] [12] [13] . However, it is not known if STIM1 function is regulated by S-nitrosylation. S-Nitrosylation is a reversible, covalent addition of the NO moiety to cysteine thiols forming an S-nitrosoprotein (SNO-protein) and is one of the principal protein post-translational modifications that regulate protein function and cell signalling [14] . S-Nitrosylation can occur when a thiol group reacts with NO in the presence of an electron acceptor. This reaction can be carried out by protein nitrosylases, which include metal-to-Cys and Cys-to-Cys nitrosylases. Over the past decade, more than 1,000 proteins, which regulate diverse cellular and organ functions, have been identified to be susceptible to S-nitrosylation [14] . Most of the greater than 50,000 proteins in the human proteome have not been assessed for S-nitrosylation, and importantly, the physiological consequences of this post-translational modification remain to be determined. Endothelial and neuronal NOS (eNOS and nNOS) are expressed in the sarcolemma and SR of cardiomyocytes, respectively. It has been shown that eNOS induces S-nitrosylation of G protein-coupled receptor kinase 2 (GRK2), β-arrestin 2 and dynamin, while nNOS S-nitrosylates Ca 2+ handling proteins including the L-type Ca 2+ channel, RyR2 and SERCA2a in cardiomyocytes [14] [15] [16] .
The luminal segment of STIM1 preceding the EF-SAM domain contains two cysteine residues (i.e. Cys49 and Cys56) which are conserved from Drosophila to humans [17] . In response to oxidative stress, Cys56 undergoes S-glutathionylation, activating STIM1 and CRAC channels in DT40 lymphocytes [18] . To date, it is not known if these cysteine residues are susceptible to S-nitrosylation by NO or whether S-nitrosylation of STIM1 regulates CRAC channel activity in mammalian cells. Here, using primary nNOS -/cardiomyocyte cell culture, HEK293 cell lines and recombinantly isolated luminal STIM1 domains we show that nNOS inhibits I CRAC and SOCE via S-nitrosylation of Cys49 and Cys56, which increases the rigidity of the protein backbone, stabilizes the Ca 2+ sensing domain and inhibits oligomerization. This suppressive effect is opposite to S-glutathionylation [18] and highlights how post-translational modifications can fine-tune the Ca 2+ sensing response of STIM1 and SOCE commensurate with a changing cellular environment.
RESULTS

STIM1 S-nitrosylation in the heart.
To assess STIM1 S-nitrosylation, neonatal mouse hearts were isolated and homogenized. S-Nitrosylated proteins were biotin-tagged with the biotinswitch protocol using ascorbic acid to selectively reduce S-NO groups. S-Nitrosylated STIM1 was subsequently detected by western blotting. Our results show that relative levels of detectable S-nitrosylated STIM1 proteins were lowered by 49% in nNOS -/compared to WT hearts (P<0.01, Fig. 1a ). Since disulfide bonds can form as a consequence of S-nitrosylation [19] , we assessed the propensity for intramolecular disulfide formation using a gel migration assay previously used for STIM1 [20] . STIM1 from WT hearts exhibited an increased mobility under non-reducing compared to reducing conditions, while STIM1 from nNOS -/or eNOS -/hearts showed no change in mobility (Fig. S1) . The data is consistent with the relatively higher levels of Snitrosylation observed for WT compared to nNOS -/samples ( Fig. 1a) . Interestingly, deficiency in eNOS lowered STIM1 S-nitrosylation by 52% ( Fig. S2 ), suggesting eNOS also causes STIM1 S-nitrosylation in the heart. S-Nitrosylation of isolated human STIM1 luminal domain (residues 23-213) protein by NO donor S-nitrosoglutathione (GSNO) was demonstrated using a fluorescein-5-maleimide labeling assay ( Fig. S3 ).
SOCE and I CRAC are increased in nNOS -/neonatal cardiomyocytes.
Since nNOS is the predominant NOS isoform in cardiomyocytes and is localized to the SR in close proximity with STIM1, the present study is focused on the role of nNOS in regulating SOCE and I CRAC . To this end, cultured neonatal cardiomyocytes were employed to analyze Ca 2+ influx using fura-2.
Baseline assessments show similar intracellular Ca 2+ levels among WT, WT+L-VNIO and nNOS -/cardiomyocytes with fura-2 ratios of 0.62±0.02, 0.68±0.03 and 0.67±0.04, respectively (P=n.s.). Cells were then incubated in Ca 2+ -free media and treated with thapsigargin (2 μ M), an SR Ca 2+ ATPase (SERCA) inhibitor, for 10 min to deplete SR Ca 2+ stores. This treatment was followed by incubation with 1.8 mM extracellular Ca 2+ , and the resulting Ca 2+ influx in cardiomyocytes was recorded using fura-2 fluorescence (Fig. 1b) . SOCE was significantly higher in nNOS -/compared to wild-type (WT) cardiomyocytes (P<0.05, Fig. 1c ). Treatment (Fig. 1d-f ). Interestingly, the amplitude of I CRAC was significantly larger in nNOS -/cells and L-VNIO treated WT cells in comparison to WT control cells (P<0.01, Fig. 1g and h) . Notably, the NO-donor GSNO (250 µM) significantly inhibited I CRAC in nNOS -/cells (P<0.05, Fig. 1f and i). To control for variability in cell size, current density (pA/pF) at -80 mV is shown in Fig. 1j . Together, these results indicate that NO inhibits I CRAC .
NO-mediated I CRAC inhibition is dependent on Cys49 and Cys56 of STIM1. Since luminal STIM1
Cys56 is susceptible to modification by oxidative stress [18, 20] , we hypothesized that the luminal Cys residues are also targets of NO-mediated modification and inhibition of I CRAC . Thus, we generated single or double mutations (i.e. Cys49Ser, Cys56Ser or Cys49Ser/Cys56Ser) into a full length monomeric cherry fluorescent protein-tagged human STIM1 (mCh-STIM1) construct.
WT, single or double cysteine mutants of mCh-STIM1 were transfected into HEK293 cells stably expressing yellow fluorescence protein (YFP)-Orai1 [21] . Expression of mCh-STIM1 and YFP-Orai1 in HEK293 cells was confirmed by red and yellow fluorescence signals, respectively.
HEK293 cells express little or no nNOS or eNOS as these proteins were not detectable by western blot analysis ( Fig. S4 ). Whole-cell voltage-clamp recordings revealed that HEK293 cells stably expressing YFP-Orai1 alone had no detectable BTP2-senstive I CRAC (Fig. S5) . In contrast, transfection of WT full length mCh-STIM1 into the YFP-Orai1 expressing HEK293 cells resulted in a BTP2-sensitive I CRAC , which was inhibited by ~45% in the presence of GSNO ( Fig.   2a ). Remarkably, the inhibitory effect of GSNO was attenuated to 16% and 9% in cells expressing Cys49Ser or Cys56Ser mCh-STIM1, respectively ( Fig. 2b and c) . Importantly, the effect of GSNO on I CRAC was completely abolished in cells expressing the Cys49Ser/Cys56Ser double mutant mCh-STIM1 ( Fig. 2d) . The I CRAC response in the present of GSNO was significantly different between WT and double mutant transfected cells while the baseline currents were similar between the two groups ( Fig. 2e) . These data suggest that Cys49 and Cys-specific S-nitrosylation ( Fig. 3b ). The largest carbon shift changes were localized to the Cα and Cβ atoms of Cys49 and Cys56, consistent with modification of the proximal sulfhydryl groups (Fig. 3c) . The chemical shift index (CSI) [22] of STIM1 24-57 calculated from the backbone chemical shifts showed that, in isolation, this region does not form regular secondary structure either with or without the NO donor. However, the random coil index (RCI) [23] revealed strikingly higher order parameters (S 2 ) for residues clustered near the Cys49 site ( Fig.   3d ), suggesting decreased mobility in the presence of GSNO compared to DTT. Thus, GSNO modifies the Cys49 and Cys56 residues, causing structural changes associated with rigidification of the residues localized around Cys49.
NO stabilizes the STIM1 luminal domain in a Cys49 and Cys56-dependent manner. We next sought to determine how the NO donor-induced structural and dynamical changes in STIM1
24-57 affect the stability of the entire luminal domain of STIM1. Thus, we assessed stability of the STIM1 23-213 protein by monitoring changes in far-UV circular dichroism (CD) signal as a function of temperature in the presence and absence of NO donors. In the absence of NO donors, the Ca 2+ -loaded STIM1 23-213 protein unfolded with a midpoint temperature of denaturation (T m ) of 62.5 ± 0.5 °C. Remarkably, either excess GSNO or sodium nitroprusside (SNP) NO donors significantly increased the thermal stability of the Ca 2+ loaded STIM1 23-213 region by ~2 °C (Fig. 3e) . In the absence of NO, the Ca 2+ -depleted luminal domain of STIM1 was highly destabilized compared to the Ca 2+ -loaded state with a T m of 41.7 ± 0.6 °C, as previously demonstrated [24] . While the stabilization observed for the Ca 2+ -loaded protein was a modest ~2 °C in the presence of the NO donors, the Ca 2+ -depleted STIM1 23-213 protein showed a more marked ~4 °C increase in T m in the presence of excess GSNO or SNP (Fig. 3f) . The Cys49Ser/Cys56Ser double mutation of STIM1 23-213 caused an overall destabilization of the protein; however, the T m values for both the Ca 2+ -loaded and Ca 2+ -depleted states were not significantly altered by the NO donors ( Fig. 3g) . Thus, NO significantly enhances the stability of the luminal domain of STIM1 in both the presence and absence of Ca 2+ in a Cys49-and Cys56dependent manner.
NO inhibits oligomerization of the STIM1 luminal domain in Cys49 and Cys56-dependent
manner. Ca 2+ depletion induced destabilization-coupled oligomerization initiates STIM1 activation and SOCE [6] [7] [8] [25] [26] [27] . Using dynamic light scattering (DLS), Ca 2+ -depleted WT STIM1 23-213 showed an earlier decay in the normalized autocorrelation function when treated with GSNO compared to DTT, indicative of smaller particle sizes. GSNO did not elicit a similar shift for the Cys49Ser/Cys56Ser protein (Fig. 4a ). The average monodisperse particle size weighted toward the largest particle was significantly smaller for the WT protein in the presence of GSNO compared to DTT, while the NO donor did not similarly affect the Cys49Ser/Cys56Ser protein ( Fig. 4b) . Regularized deconvolution of the polydisperse sizes showed a distinct distribution of ~monomer/dimer hydrodynamic radii for WT protein in the presence of the NO donor that was absent with DTT treatment and with the Cys49Ser/Cys56Ser protein ( Fig. 4c) .
Since the smallest observable radii correspond to the majority of the DLS signal due to the fact that light scattering intensity is proportional to size to the sixth power, this in vitro effect is marked [28] . Our data suggest that in the absence of Ca 2+ and in the presence of the NO donor, oligomerization of the STIM1 luminal domain is suppressed via a mechanism that is dependent on the Cys49 and Cys56 residues.
NO inhibits mCh-STIM1 puncta formation and co-localization with YFP-Orai1. STIM1
puncta formation and co-localization with Orai1 at SR/ER-plasma membrane junctions is a hallmark of SOCE initiation [29, 30] . To assess the effect of NO on STIM1 puncta formation,
HEK293 cells stably expressing YFP-Orai1 and transiently expressing WT or
Cys49Ser/Cys56Ser mCh-STIM1 were bathed in extracellular Ca 2+ -free medium which contained thapsigargin (2 μ M) for 10 min. Confocal imaging revealed that both WT and Cys49Ser/Cys56Ser mCh-STIM1 formed puncta co-localized with YFP-Orai1, indicative of STIM1 activation ( Fig. 4d and e) . Notably, treatment with GSNO (250 µM) prevented puncta formation in WT mCh-STIM1 expressing cells but not in Cys49Ser/Cys56Ser mCh-STIM1 expressing cells ( Fig. 4d and e ). Image quantification using Pearson coefficients shows a significant mCh-STIM1 and YFP-Orai1 colocalization in both WT and double mutant transfected cells after thapsigargin treatment (P<0.01, Fig. S6 ). In contrast, incubation with GSNO for 10 min decreased thapsigargin-induced mCh-STIM1 and YFP-Orai1 colocalization in WT (P<0.05) but not in double mutant transfected cells ( Fig. S6) . These data are in full agreement with in vitro observations showing suppressed oligomerization of S-nitrosylated STIM1 luminal region in a Cys49 and Cys56-dependent manner.
DISCUSSION
S-Glutathionylation of Cys56 increases the activity of STIM1 and SOCE due to a weakening of STIM1 Ca 2+ binding affinity [18] . In the present study, the inhibitory effect of Snitrosylation is opposite to the stimulatory effect of STIM1 S-glutathionylation in non-excitable cells. Further, a propensity for STIM1 Cys49 and Cys56 intramolecular disulfide formation has been previously reported, and blocking this oxidative modification by mutation of the Cys residues to Ala suppresses SOCE in mouse embryonic fibroblasts [20] . This observation is in contrast to data from DT40 cells which showed constitutive SOCE when expressing a STIM1
double Cys49Ala and Cys56Ala mutant [18] . Thus, the phenotype may depend on the cell type used and experimental conditions. Here, we observed a decreased propensity for STIM1 intramolecular disulfide formation in mouse hearts deficient in eNOS and nNOS compared to
WT, suggesting a crosstalk between S-nitrosylation and disulfide modifications in cardiomyocytes.
To ascertain the molecular mechanisms underlying the inhibition of STIM1-mediated SOCE by NO, we used recombinant STIM1 proteins corresponding to residues 24-57 and 23-213.
Our NMR data revealed that NO modifies Cys49 and Cys56 residues causing structural perturbations associated with decreased mobility of the STIM1 24-57 region. We subsequently showed that the decreased dynamics by NO treatment of the full luminal STIM1 domain encompassing residues 23-213 not only increased the stability of the domain, but also suppressed the oligomerization propensity of the domain in the absence of Ca 2+ . Further, the NO donors did not affect these biophysical properties of the Cys49Ser/Cys56Ser double mutant STIM1 23-213
protein, suggesting that the cysteine residues are critical to STIM1 stabilization. In line with these in vitro data we demonstrated that NO inhibits puncta formation of full length mCh-STIM1 in HEK293 cells via a mechanism that is dependent on the Cys49 and Cys56 residues.
Collectively, our data suggest a signaling model whereby NO stabilizes the STIM1 protein, inhibits STIM oligomerization and attenuates I CRAC via S-nitrosylation of Cys49 and Cys56 residues through a structural mechanism that involves decreased mobility of the short non- A previous study revealed a consensus I/L-X-C-X 2 -D/E motif which is necessary and sufficient for S-nitrosylation of targets from an inducible NOS (iNOS)-S100A8-S100A9
complex [31] . However, this motif is not present in STIM1 proteins suggesting an Snitrosylation mechanism distinct from iNOS and S100 involvement. Nevertheless, we demonstrate that STIM1 S-nitrosylation occurs in WT hearts and is decreased in nNOS -/and eNOS -/hearts. While the precise role of eNOS in I CRAC regulation remains to be determined, we
show that nNOS-mediated STIM1 S-nitrosylation inhibits I CRAC and SOCE in neonatal cardiomyocytes. STIM1 is expressed at significant levels in the neonatal heart and its expression is reduced with a lower SOCE activity in the adult heart but can be induced by cardiac hypertrophy [32] . We now reveal that NO-mediated inhibition of STIM1 activity through Snitrosylation may also contribute to the lower SOCE in the normal heart. Thus, a functional NO signaling may limit SOCE and cardiac hypertrophy via STIM1 S-nitrosylation. Given that CRAC channels are activated in a graded manner with a steep drop in activity at stoichiometric STIM1:Orai1 binding ratios below 2, not all STIM1 molecules within each channel complex are required to undergo S-nitrosylation to appreciably inhibit CRAC channel activity [33, 34] . Under pathological conditions such as heart failure, NO bioavailability is reduced because of higher ROS levels [35, 36] . Under these conditions, it is possible that STIM1 S-nitrosylation is decreased while S-glutathionylation is increased, leading to much higher I CRAC and SOCE, which may contribute to cardiac hypertrophy.
The heart also expresses STIM1L, a splicing variant of STIM1 with the same N-terminal Cys residues and STIM2, which has three Cys residues (Cys15, Cys53 and Cys60) at the luminal region [37, 38] . Interestingly, STIM1L activates SOCE immediately upon Ca 2+ store depletion and allows for repetitive cytosolic Ca 2+ releases [37] . STIM2 has been shown to mediate increases in resting cytosolic free Ca 2+ levels in vascular smooth muscle cells (VSMC) and
contribute to VSMC proliferation [39] . Additionally, a rare de novo interstitial duplication at 4p15.2, where several candidate genes including STIM2 are located, may potentially cause severe congenital heart defects, limb anomalies, hypogonadism, distinctive facial features, preand postnatal developmental delay, and mild cognitive impairments [40] . In the present study, basal intracellular Ca 2+ levels in neonatal cardiomyocytes are not significantly altered by nNOS.
However, we have previously shown that peak Ca 2+ transient during electric stimulation is increased in nNOS -/adult mouse cardiomyocytes compared to WT cells [16] . Whether STIM1L and STIM2 can be S-nitrosylated, and how this modification regulates SOCE and intracellular Ca 2+ levels mediated by these two STIM isoforms in cardiomyocytes remain to be investigated.
In summary, the present study shows that NO can regulate STIM1 activation and SOCE through S-nitrosylation in mammalian cells. Remarkably, our work reveals that the conserved Cys residues on the N-terminal region endow STIM1 with a dynamic functional sensitivity to different thiol modifications depending on the properties of the immediate cellular milieu.
Considering the universality of NO and Ca 2+ signaling in health and disease, we believe the Primary culture of neonatal cardiomyocytes. Neonatal cardiomyocytes were isolated and cultured as described previously [41] [42] [43] . Forty-eight hours after seeding, cells were used for Ca 2+ imaging and patch clamp.
Ca 2+ imaging and SOCE measurements. Ca 2+ imaging was performed using excitation using a deltascan monochrometer system (Photon Technology International, London, ON, Canada) with an automated fluorescence microscope and CCD camera [44] . Neonatal cardiomyocytes were plated on 0.01% polylysine plus 0.1% gelatin-coated Assistant-Präzision coverslips (Deckgläser, Germany). Cardiomyocytes were loaded with 1 μ M Fura-2AM (Invitrogen) in extracellular solution (in mM, 140 NaCl, 5 KCl, 1.8 CaCl 2 , 1 MgCl 2 , 10 glucose, and 10 Hepes) for 30 min at room temperature. Next, cells were washed with extracellular solution and kept in this solution until use. Fluorescence intensity at 510 nm was measured with alternating 345 and 380 nm excitation. A standard protocol referred as "Ca 2+ re-addition" was used to trigger SOCE [45] , in which cells were initially exposed to Ca 2+ -free medium containing thapsigargin (2 μ M) to deplete SR Ca 2+ stores. Then, Ca 2+ (1.8 mM) was restored to the medium, and Ca 2+ influx was recorded. Data were analyzed using ImageMaster software and shown as 340/380 nm ratios at indicated time points or as time-ratio traces translated from the images.
Analysis of STIM1 S-nitrosylation in tissues. STIM1 S-nitrosylation was assessed using an Snitrosylation Biotin Switch Protein Detection Kit (Cayman Chemical, Ann Arbor, MI). Briefly, neonatal hearts from WT and nNOS -/mice were homogenized in RIPA buffer and lysates were centrifuged at 10,000g to remove unbroken tissues. After protein concentrations were determined by Lowry assay, 500 μg total protein was successively blocked with N-ethylmaleimide, ascorbate reduced and labeled with biotin according to the manufacturer protocol. The free labeling reagents were removed by acetone precipitation, and the pellets were resuspended in 10%
HENS buffer/90% neutralization buffer [46] . Biotinylated proteins were pulled out using streptavidin agarose beads and subsequently separated on an 8% SDS-PAGE denaturing gel. S-Nitrosylated STIM1 was indirectly detected as a biotinylated protein after transfer to PVDF membrane by western blotting using a rabbit anti mouse STIM1 antibody (C-terminal; Sigma
Aldrich. St. Louis, MO) diluted 1:1500. Aliquots of tissue lysates containing 75 µg of total protein were assessed by western blotting using the same anti-STIM1 antibody as loading controls. To assess STIM1 mobility shift, heart homogenates (50 µg total protein) were run on 5% SDS-PAGE gel under reducing or non-reducing conditions in the presence or absence of 1% β mercaptoethanol, respectively [20] .
Recombinant protein expression and purification of STIM1 23-213 and 24-57. STIM1 23-
214 was expressed using a pET-28a vector transformed into BL21 ΔE3 Escherichia coli as previously described [6, 24] . Briefly, proteins were pulled out of guanidinium solubilized cell lysate using Ni-nitrilotriacetic acid affinity resin (Qiagen). Refolding was done in 20 mM Tris, 300 mM NaCl, 5 mM CaCl 2 , 1 mM DTT, pH 8 by dialysis. The 6×His tags were removed by overnight thrombin digestion (~1 U mg -1 of protein), and the proteins were further purified by Superdex S200 10/300 GL size exclusion chromatography (GE Healthcare). Greater than 95% purity was confirmed by SDS-PAGE and Coomassie blue staining. The Cys mutations were introduced using the QuickChange PCR method (Agilent) and confirmed by sequencing.
Human STIM1 residues 24-57 (NCBI accession NP_003147) was subcloned into the HSQC and HNCACB experiments [47] . The two-and three-dimensional spectra were processed, and resonance assignments were made using NMRPipe and XEASY, respectively [48, 49] . Statistical Analysis. All data are expressed as mean ± SEM. One-way analysis of variance (ANOVA) followed by Tukey's post hoc test was used to compare differences among groups.
Differences were considered statistically significant at P<0.05. Figure 4 
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